Aristotle University Of Thessaloniki (AUTH)
Μελέτη του αγγειακού αυξητικού παράγοντα του ενδοθηλίου, σε ασθενείς με προχωρημένο καρκίνο της κεφαλής και του τραχήλου
Abstract
dc:descriptionBackground: The main prognostic variables of head and neck squamous cell carcinoma (HNSCC) are the location and size of the tumor and the presence of cervical lymph node metastasis. Differential gene expression of members of the VEGF family is a common feature in HNSCC. To elucidate the prognostic value and the interrelation of these factors we performed a detailed gene expression analysis within HNSCC tissue samples. Methods: We analyzed fresh frozen tissue from 41 recurrent HNSCC tumors stored at -80°C. RNA was isolated with the RNeasy kit (Qiagen, Inc.), followed by real time TaqMan PCR for the expression of the VEGF family genes (VEGF-A total, VEGF-A₁₂₁ VEGF-A₁₆₅, VEGF-A₁₈₉, VEGF-B, VEGF-C and VEGF-D) and their receptors VEGF-R1(Flt1), VEGF-R2(KDR/Flk1) and VEGF-R3(Flt4). Raw data (Ct values) were normalized to GAPDH expression (housekeeper gene) and candidate gene expression between patient groups with differential clinical outcomes was analyzed by using the SPSS 11.0.1 software package. Median patient follow-up from initial diagnosis of the relapse was 28 months. Results: Overexpression of VEGF-A total, VEGF-A₁₆₅ and VEGF-A₁₈₉ was prominent in most tumors, but did not appear to have any prognostic value. Both VEGF-A total and VEGF-A₁₆₅ significantly correlated with smoking abuse (number of cigarettes). However, VEGF-C expression was significantly higher in the tumors of patients with poor overall survival (<24 months). Median survival of patients with tumor VEGFC expression was calculated to be 42 months (Kaplan-Meier Survival Analysis), compared to 182 months in the rest of the patients. Conclusions: We have found that elevated VEGFC expression correlates with poor outcome in recurrent HNSCC patients. VEGFC preferably binds to the VEGFR3, which is predominantly expressed on lymphatic vessels. Overexpression of VEGFC may therefore result in the establishment of intratumoral lymphatic vessels, which have been shown to facilitate and enhance the dissemination of tumor cells into lymph nodes and the formation of distant metastases. We conclude that the determination of VEGFC expression may be of high prognostic value in HNSCC patients and that it may serve in the early identification of aggressive HNSCC subtypes.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Angouridakis, Nikolaos
- Αγγουριδάκης, Νικόλαος-Εμμανουήλ
Subjects
dc:subject × 14- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας (VEGF)
- Καρκίνος κεφαλής τραχήλου
- Καρκίνωμα από πλακώδες επιθήλιο
- VEGF ( Vascular endothelium growth factor)
- Vascular endothelial growth factor (VEGF)
- Head and neck cancer
- Squamous cell carcinomas
- Relapse
- Recurrence
- Angiogenesis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19564